Next, please read the article "Optimal Duration of Allergen Immunotherapy" included on the following page. This article, published in The Journal of Allergy and Clinical Immunology in November 2014, explores safety and risk factors related to both sublingual immunotherapy and venom immunotherapy, long-term treatment responses to sublingual and subcutaneous immunotherapy, and strategies to improve treatment compliance in immunotherapy patients.
The article will open in a pop-up window when you click "Next" below. Once you are finished reading the article close the window and follow the directions to proceed.
PLEASE NOTE: When originally published, the American Board of Allergy and Immunology counted completion of this article as meeting the self-assessment requirements of their Maintenance of Certification program. This option expired in October 2015.